Live Science Plus
Latest about Viruses, Infections & Disease
Color blindness linked to lower bladder cancer survival, early study hints
People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed later, a study suggests.
Viruses that evolved on the space station and were sent back to Earth were more effective at killing bacteria
Near-weightless conditions can mutate genes and alter the physical structures of bacteria and phages, disrupting their normal interactions in ways that could help us treat drug-resistant infections.
Why is flu season so bad this year?
Flu season in the U.S. is particularly bad this year, and a new branch of the flu family tree may be to blame.
This is SPARDA: A self-destruct, self-defense system in bacteria that could be a new biotech tool
A bacterial defense system called SPARDA employs kamikaze-like tactics to protect cells and could be useful in future biotechnologies.
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
Blood tests that look for over a dozen cancers are being developed. But how soon will they help patients?
It matters what time of day you get cancer treatment, study suggests
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
Cassius the giant crocodile died from sepsis after 40-year-old dormant infection burst from 'abscess,' necropsy reveals
Cassius was an 18-foot-long saltwater crocodile living in captivity in Marineland Crocodile Park in Australia. He died last year at the age of about 120, and we finally know why.
Man caught rabies from organ transplant after donor was scratched by skunk
A Michigan man died of rabies despite having no recent exposure to a potentially infected animal.
Widespread cold virus you've never heard of may play key role in bladder cancer
Scientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA.
Science history: Female chemist initially barred from research helps develop drug for remarkable-but-short-lived recovery in children with leukemia — Dec. 6, 1954
In December 1954, Gertrude Elion and colleagues described a new compound they had developed that sent children with leukemia into remission. It would guide a new approach to "rational drug design."
